NKO
NKO, licence 80064549: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Neptune Huile de Krill, Neptune Krill Oil
- Licence holder
- Biodroga Nutraceuticals Inc.
- NPN or DIN-HM
- 80064549
- Status
- Active licence
- Licence date
- 9 October 2015
- Revision date
- 17 March 2023
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de krill Source : Euphausia superba - en entier Potency : 45.0 mg Eicosapentaenoic acid | 300.0 mg | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 126.0 mg Phospholipids | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 0.3 mg Esterified astaxanthin | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 90.0 mg Omega-3 Fatty acids | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 27.0 mg Docosahexaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Eau purifiée, Glycérol, Ethylvanilline, Sorbitol, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 1.0 Tous les jours |
| Adultes | Not specified | 2.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
1- source of omega-3 fatty acids for the maintenance of good health 2- source of EPA and DHA for the maintenance of good health 3- Helps to reduce pain associated with osteoarthritis 4- Helps to reduce C reactive protein levels, a clinical marker of inflammation
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if allergic to shellfish.
Source
Official Health Canada record, licence 80064549
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.